David H. Mack, Ph.D.

Frequently asked questions

Who is David H. Mack, Ph.D.?

David H. Mack, Ph.D., is President and CEO of PMV Pharmaceuticals, which he co-founded with biologists Arnold Levine and Thomas Shenk. He previously worked as a general partner at Alta Partners from 2002 to 2013, co-founded Eos Biotechnology, headed cancer biology at Affymetrix from 1994 to 1997, and was a member of the PCR Invention Group at Cetus in the mid-1980s. Mack holds a Ph.D. from the University of Chicago and a B.A. in molecular biology from the University of California, Berkeley, has co-authored more than 30 scientific articles, is named on 26 issued US patents, and has served on the boards of companies including Aerie Pharmaceuticals, aTyr Pharmaceuticals, Aduro Biotech, and Sutro Biopharma.

Where does David H. Mack, Ph.D. work?

David H. Mack, Ph.D. is Founder of PMV Pharma.

What companies did David H. Mack, Ph.D. found?

David H. Mack, Ph.D. founded PMV Pharma.

Where did David H. Mack, Ph.D. go to school?

David H. Mack, Ph.D. studied at Stanford University School of Medicine (Postdoctoral Fellow, Microbiology and Immunology); University of Chicago (Doctor of Philosophy (Ph.D.), Molecular Genetics and Cell Biology); University of California, Berkeley (Bachelor of Arts (B.A.), Molecular Biology).